Intellectual Asset Management’s (IAM) Patent 1000 annual patent rankings have just been released. Wrays is pleased to advise that we have been recognised as one of Australia’s leading patents firms delivering exceptional IP services with profound insight in patent matters. The IAM Patent 1000 rankings are regarded as the definitive directory for those seeking to identify world-class, private practice patent …
Richard Baddeley Builds Wrays Engineering & Technology Team
One of Australia’s leading Intellectual Property Law Firms, Wrays, has announced the hiring of Principal, Richard Baddeley. Richard joins Wrays after 31 years at Watermark and after Watermark was subsumed into the listed IPH Group of entities. This high-profile appointment is a coup for Wrays with Richard regarded as ‘a stalwart’ of the Intellectual Property Industry. Richard is the immediate …
Wrays Builds Engineering & Technology Team
Wrays is pleased to announce the appointment of Richard Baddeley who will officially join the firm as a Principal on 1 June 2020. Richard joins Wrays after 31 years at Watermark and after Watermark was subsumed into the listed IPH Group of entities. Richard provides advice on all aspects of intellectual property and has built an impressive track record acting …
Dr Mary Turonek Boosts Wrays’ Chemistry, Resources and Oil & Gas Teams
One of Australia’s leading Intellectual Property Law Firms, Wrays, has announced the hiring of Principal, Dr Mary Turonek. Mary joins the firm from FB Rice. With over 20 years experience Mary adds significant weight to the already-established Perth Chemistry, Resources and Oil and Gas teams. Mary has, in particular, provided IP protection and management for a broad range of Australian …
Staying Connected During COVID-19
As we all continue to navigate this time of change brought about by COVID-19, we wanted to share with you the additional measures that Wrays is taking to ensure the well-being of our employees, clients and our community. Whilst this is clearly a disruptive time, what won’t change is our commitment to our delivery of high-quality intellectual property advice to …
Novel Coronavirus (COVID-19) – A notice to our visitors
As the impact of the novel coronavirus (COVID-19) continues to rise, we feel it’s important to update you on the measures we are taking to ensure the well-being of our employees, clients, guests and the community at large. We are closely monitoring recommendations from WHO, Australian Government Department of Health and other health organizations, and are taking proactive steps to …
Celebrating 100 Years of Innovative Minds
This year marks the 100 year anniversary of Wrays. With our origins dating back to 1920, our centenary year is an important and exciting milestone in the evolution and journey of our firm. Australia boasts a long and rich culture of innovation that has created change around the world. We are proud to be part of that with our people …
Curtin Ignition Program 2019 – scholarship applications open now!
Collaboration and augmentation are the foundational principles of innovation – Vaclav Smil We understand the importance of collaboration and the need for guidance in the early stages of commercialisation. That is why we are proud supporters of the Curtin Ignition program – an intensive training program for aspiring entrepreneurs and innovators to trial and prepare high growth business ideas for …
Wrays supporting Women in Tech in WA
Priding ourselves on supporting great innovators of present and future, we are excited to announce our partnership with WiTWA – Women in Tech WA. WiTWA is a Perth-based, not for profit organization, providing a framework for women in tech to extend their networks and expand their knowledge on a broad range of professional topics. The organisation encourages young people through …
Wrays Chairman secures landmark patent opposition win
In the recent Australian patent office decision of Gary B Cox v MacroGenics, Inc. [2019] APO 13, Wrays’ Chairman, Gary Cox, successfully opposed the grant of Macrogenics, Inc.’s Australian patent application no. 2012259162 directed to polypeptides with extended serum half-lives. The decision is one of only a small number of Australian patent office decisions where a patent specification was held …